Linatab 5 mg is an effective oral medication used for the management of type 2 diabetes mellitus in adults. It helps improve glycaemic control either as a monotherapy when diet and exercise are insufficient, or in combination with other antidiabetic drugs such as metformin or sulfonylureas when single therapy does not achieve adequate control. Linatab 5 mg is particularly useful for patients who cannot tolerate metformin due to renal impairment or other contraindications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Dipeptidyl Peptidase-4 (DPP-4) inhibitor

Pharmacology

Linatab 5 mg works by inhibiting the enzyme DPP-4, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Incretins are hormones that:

• Stimulate glucose-dependent insulin secretion from pancreatic beta cells

• Suppress glucagon release from pancreatic alpha cells

By prolonging the activity of incretin hormones, Linatab 5 mg helps reduce blood glucose levels in a controlled and predictable manner, lowering the risk of hyperglycemia without causing significant hypoglycemia when used alone.

Indications

Linatab 5 mg is indicated for:

• Monotherapy: For patients with type 2 diabetes who cannot achieve glycemic control through diet and exercise alone, and who are intolerant or have contraindications to metformin.

• Combination therapy: For patients who need additional glycemic control when diet, exercise, and metformin alone are insufficient. It may be combined with other agents such as sulfonylureas.

Dosage and Administration

• Adults: Take one tablet of Linatab 5 mg once daily, at any time of the day, with or without food.

• Combination therapy: When used with sulfonylurea, a lower sulfonylurea dose may be required to reduce the risk of hypoglycemia.

• Renal impairment: No dose adjustment is required.

Contraindications

• Hypersensitivity to Linatab 5 mg or any of its excipients

Side Effects

Linatab 5 mg is generally well tolerated. Potential adverse effects may include:

• Hypoglycemia (especially in combination with sulfonylurea or insulin)

• Nasopharyngitis

• Cough

• Rare cases of pancreatitis

Precautions and Warnings

• Avoid use in patients with known hypersensitivity to DPP-4 inhibitors or excipients

• Monitor for symptoms of pancreatitis, including persistent severe abdominal pain

• Use cautiously in patients with a history of renal or hepatic disorders

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Linatab 5 mg is a weak CYP3A4 inhibitor but generally does not cause clinically significant interactions with:

• Metformin

• Glyburide

• Simvastatin

• Warfarin

• Digoxin

• Oral contraceptives

Pregnancy and Lactation

• Pregnancy: Category B. Use only if clearly needed.

• Lactation: Unknown if excreted in breast milk; caution is advised.

Storage Conditions

Store in a dry place, away from heat and light. Keep out of reach of children.

Mode of Action

Linatab 5 mg inhibits DPP-4, preventing the degradation of GLP-1 and GIP. This enhances insulin secretion and suppresses glucagon release, improving blood glucose regulation in type 2 diabetes patients while minimizing the risk of hypoglycemia.